Vaccines targeting cancer stem cells: are they within reach?

Madhav V Dhodapkar1, Kavita M Dhodapkar

  • 1Departments of Medicine, Immunobiology and Pediatrics, Yale University, New Haven, CT, USA. madhav.dhodapkar@yale.edu

Insights

Cancer stem cells (CSCs) are key to tumor growth and recurrence. Targeting CSCs and their associated genes may offer a novel strategy for durable cancer immunity and prevention.

Area of Science:

  • Oncology
  • Immunology
  • Stem Cell Biology

Background:

  • The cancer stem cell (CSC) hypothesis is gaining traction due to increased understanding of tumor heterogeneity.
  • CSCs are implicated in tumor recurrence and resistance to therapy.
  • The CSC hypothesis has significant implications for developing effective cancer immunotherapies.

Purpose of the Study:

  • To explore the role of CSCs in cancer immunity.
  • To investigate antigenic targets on CSCs and immune system responses.
  • To evaluate the potential of targeting CSCs for durable antitumor immunity and cancer prevention.

Main Methods:

  • Review of recent studies on CSCs, tumor immunity, and antigenic targets.
  • Analysis of genes regulating stemness in CSCs and their overlap with embryonic stem cells.
  • Exploration of immunologic strategies targeting CSC-associated pathways.

Main Results:

  • Novel insights into antigenic targets on CSCs and immune system interactions.
  • Identification of key genes regulating CSC stemness and self-renewal.
  • Evidence suggesting CSCs are plastic but rely on a core set of stemness genes.

Conclusions:

  • Targeting CSCs holds promise for achieving durable antitumor immunity.
  • Immunologic strategies focused on stemness-associated pathways could prevent various cancers.
  • Understanding CSC biology is crucial for advancing cancer immunotherapy and prevention.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...